Announcements

AGCO Corporation (NYSE: AGCO) filed a Form 8-K on August 3, 2026, disclosing executive leadership changes effective August 1, 2026, including the appointment of Indira Agarwal as Senior Vice President and Chief Financial Officer.

Autolus Therapeutics plc filed a Form 8-K on July 30, 2026, disclosing that it entered into a senior secured notes facility of up to $250.0 million with Perceptive Credit Holdings V, LP as administrative agent, and simultaneously issued warrants to purchase up to 3,500,000 …

Autolus Therapeutics plc filed a Form 8-K on August 3, 2026, announcing an increase to its full-year 2026 net product revenue guidance for AUCATZYL, anticipated Q2 2026 revenue figures, gross margin expectations, a new credit facility, and an updated cash runway outlook.

Petco Health and Wellness Company, Inc. filed a current report on August 3, 2026, disclosing the resignation of director Cameron Breitner and the appointment of Jeffrey Naylor as an independent Class I director and Chair of the Audit Committee, both effective August 1, 2026.

Avidbank Holdings, Inc. (NASDAQ: AVBH) filed a current report on Form 8-K dated August 3, 2026, disclosing the appointment of Jonathan M. Dale as President of both the company and its wholly owned subsidiary, Avidbank, a California state-chartered bank headquartered in San Jose, California.

Indivior Pharmaceuticals, Inc. (NASDAQ: INDV) filed a current report on August 1, 2026, disclosing that it had entered into an Agreement and Plan of Merger with Supernus Pharmaceuticals, Inc., under which Supernus will become a wholly owned subsidiary of Indivior and the combined entity …

Indivior Pharmaceuticals, Inc. filed a Form 8-K on August 3, 2026, under Regulation FD, disclosing the execution of an Agreement and Plan of Merger dated August 1, 2026, between Indivior, Supernus Pharmaceuticals, Inc., and Artemis Merger Sub Inc., a wholly owned subsidiary of Indivior.